Pliant Therapeutics (PLRX) PT Lowered to $49 at Oppenheimer
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.17 +3.54%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Oppenheimer analyst Jeff Jones lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $49.00 (from $52.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Bank Rakyat Indonesia Persero Tbk PT (BBRI:IJ) (BKRKF) PT Raised to IDR2,860 at Macquarie
- Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
